Lifecore Biomedical, Inc. (LFCR) bonds
Close on Nov 17, 2026Market cap $241.88MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Lifecore Biomedical reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
When the debt comes due
Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2025
From the debt maturity table in the annual report (filing). “Later” is everything due after year five.
Notes and loans outstanding
As tagged in Lifecore Biomedical's 10-Q for the period ended Jun 30, 2026
| Issue | Coupon | Amount issued | Carrying value |
|---|---|---|---|
| Finance lease liability | – | – | $5.79M |
| Leaseback liability with related party | – | – | $5.41M |
| Revolving credit facility | – | – | $0 |
| Term Loan Credit Agreement | 3.00% | $142.27M | – |
| Term loan credit facility with related party | 10.00% | – | $192.73M |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size |
|---|---|
| Revolving Credit Agreement | $40.00M |
| Revolving Credit Agreement, FILO Tranche | $2.50M |
See a number that looks wrong?